The Lancet Neurology in conversation with

A podcast by The Lancet Group - Thursdays

Thursdays

Categories:

187 Episodes

  1. Evidence-based support for autistic people across the lifespan

    Published: 28/04/2020
  2. Oral immunomodulating therapies in relapsing MS

    Published: 19/03/2020
  3. The global burden of neurological conditions

    Published: 6/11/2019
  4. Blood pressure and brain structure

    Published: 13/09/2019
  5. Stroke genetics

    Published: 21/05/2019
  6. Next-generation sequencing and clinical neurology

    Published: 12/04/2019
  7. Role of astroglia in Alzheimer's disease

    Published: 14/03/2019
  8. Sleep disturbance and dementia risk

    Published: 13/02/2019
  9. Frailty and Alzheimer's

    Published: 22/01/2019
  10. Stroke–heart syndrome

    Published: 22/11/2018
  11. Epileptic seizures

    Published: 16/10/2018
  12. Thrombectomy for ischaemic stroke

    Published: 2/10/2018
  13. Cerebral white matter demyelination in multiple sclerosis

    Published: 18/09/2018
  14. Autoimmune encephalitis after herpes simplex encephalitis

    Published: 24/07/2018
  15. Network imaging biomarkers

    Published: 16/06/2018
  16. Progressive multifocal leukoencephalopathy

    Published: 4/05/2018
  17. Antiepileptic drugs and risk of congenital malformation

    Published: 30/04/2018
  18. Seizure detection and reporting in epilepsy: The Lancet Neurology: February 13, 2018

    Published: 14/02/2018
  19. MS McDonald criteria revisions: The Lancet Neurology: February 2018

    Published: 19/01/2018
  20. GWAS on dementia with Lewy bodies: The Lancet Neurology: January, 2018

    Published: 16/12/2017

4 / 10

Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.

Visit the podcast's native language site